STOCK TITAN

Director files Form 144 to sell shares (NASDAQ: VRTX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer reports proposed insider sale and recent transactions. The filing shows 2,437 restricted common shares that vested on 02/13/2026 as compensation. It also discloses a reported sale of 4,910 common shares on 02/25/2026 by Duncan J. McKechnie for $2,394,365.00.

The notice was submitted under Form 144 and lists Fidelity Brokerage Services LLC as the broker. Timing and aggregated proceeds for any proposed disposition are limited to the amounts shown in the filing.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records a restricted share vesting and a recent reported sale by an insider.

The excerpt lists 2,437 restricted common shares vesting on 02/13/2026 under compensation, and a reported disposition of 4,910 common shares on 02/25/2026

Holder identity for the sale is stated as Duncan J. McKechnie with an aggregate amount shown as $2,394,365.00. The broker is listed as Fidelity Brokerage Services LLC, and the filing is on Form 144, which notifies the SEC of proposed resale transactions under resale rules.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the VRTX Form 144 disclose about recent insider activity?

It discloses a reported sale of 4,910 common shares on 02/25/2026 for $2,394,365.00. The filing also shows 2,437 restricted shares that vested on 02/13/2026 as compensation.

Who is listed as the seller in the VRTX Form 144 filing?

The filing identifies Duncan J. McKechnie as the reporting person tied to the 4,910-share sale on 02/25/2026. Broker information lists Fidelity Brokerage Services LLC in the form's broker fields.

How many shares vested and when, according to the VRTX filing?

The form records 2,437 restricted common shares vesting on 02/13/2026 under a compensation event. That vesting date is shown explicitly in the securities-to-be-sold section of the filing.

Does the VRTX Form 144 show aggregate proceeds for recent sales?

Yes; the reported sale on 02/25/2026 by Duncan J. McKechnie shows aggregate consideration of $2,394,365.00. Other monetary fields appear in the excerpt but are not labeled as total proceeds for additional transactions.

Which broker-dealer is named in the VRTX Form 144 excerpt?

The broker-dealer listed is Fidelity Brokerage Services LLC at a Rhode Island address. That broker appears in the securities-to-be-sold section associated with the filing's execution details.
Vertex Pharmaceuticals Inc

NASDAQ:VRTX

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

117.06B
252.97M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON